360 related articles for article (PubMed ID: 35384591)
41. Survival following treatment for intracranial ependymoma: a review.
Tamburrini G; D'Ercole M; Pettorini BL; Caldarelli M; Massimi L; Di Rocco C
Childs Nerv Syst; 2009 Oct; 25(10):1303-12. PubMed ID: 19387655
[TBL] [Abstract][Full Text] [Related]
42. Long-term outcomes of spinal ependymomas: an institutional experience of more than 60 cases.
Savoor R; Sita TL; Dahdaleh NS; Helenowski I; Kalapurakal JA; Marymont MH; Lukas R; Kruser TJ; Smith ZA; Koski T; Ganju A; Sachdev S
J Neurooncol; 2021 Jan; 151(2):241-247. PubMed ID: 33179213
[TBL] [Abstract][Full Text] [Related]
43. Ependymomas and ependymoblastomas in children.
Dohrmann GJ; Farwell JR; Flannery JT
J Neurosurg; 1976 Sep; 45(3):273-83. PubMed ID: 948014
[TBL] [Abstract][Full Text] [Related]
44. A systematic review of treatment outcomes in pediatric patients with intracranial ependymomas.
Cage TA; Clark AJ; Aranda D; Gupta N; Sun PP; Parsa AT; Auguste KI
J Neurosurg Pediatr; 2013 Jun; 11(6):673-81. PubMed ID: 23540528
[TBL] [Abstract][Full Text] [Related]
45. Supratentorial ependymoma in childhood: more than just RELA or YAP.
Zschernack V; Jünger ST; Mynarek M; Rutkowski S; Garre ML; Ebinger M; Neu M; Faber J; Erdlenbruch B; Claviez A; Bielack S; Brozou T; Frühwald MC; Dörner E; Dreschmann V; Stock A; Solymosi L; Hench J; Frank S; Vokuhl C; Waha A; Andreiuolo F; Pietsch T
Acta Neuropathol; 2021 Mar; 141(3):455-466. PubMed ID: 33481105
[TBL] [Abstract][Full Text] [Related]
46. Latest classification of ependymoma in the molecular era and advances in its treatment: a review.
Yamaguchi J; Ohka F; Motomura K; Saito R
Jpn J Clin Oncol; 2023 Jul; 53(8):653-663. PubMed ID: 37288489
[TBL] [Abstract][Full Text] [Related]
47. Ependymal tumors in childhood.
Agaoglu FY; Ayan I; Dizdar Y; Kebudi R; Gorgun O; Darendeliler E
Pediatr Blood Cancer; 2005 Sep; 45(3):298-303. PubMed ID: 15770637
[TBL] [Abstract][Full Text] [Related]
48. Genetic expression profiles of adult and pediatric ependymomas: molecular pathways, prognostic indicators, and therapeutic targets.
Nagasawa DT; Trang A; Choy W; Spasic M; Yew A; Zarinkhou G; Garcia HM; Yang I
Clin Neurol Neurosurg; 2013 Apr; 115(4):388-99. PubMed ID: 23374238
[TBL] [Abstract][Full Text] [Related]
49. [Therapeutic results of eight patients with intracranial ependymomas].
Sasajima T; Takahashi M; Kinouchi H; Suzuki A; Mizoi K
No To Shinkei; 2003 Mar; 55(3):233-40. PubMed ID: 12728504
[TBL] [Abstract][Full Text] [Related]
50. [Precision Medicine for Ependymoma].
Gomi A
No Shinkei Geka; 2022 Jan; 50(1):91-100. PubMed ID: 35169089
[TBL] [Abstract][Full Text] [Related]
51. Intracranial ependymomas in childhood. Survival and functional results of 47 cases.
Pierre-Kahn A; Hirsch JF; Roux FX; Renier D; Sainte-Rose C
Childs Brain; 1983; 10(3):145-56. PubMed ID: 6872622
[TBL] [Abstract][Full Text] [Related]
52. Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging.
Pagès M; Pajtler KW; Puget S; Castel D; Boddaert N; Tauziède-Espariat A; Picot S; Debily MA; Kool M; Capper D; Sainte-Rose C; Chrétien F; Pfister SM; Pietsch T; Grill J; Varlet P; Andreiuolo F
Brain Pathol; 2019 May; 29(3):325-335. PubMed ID: 30325077
[TBL] [Abstract][Full Text] [Related]
53. Intracranial ependymomas: a review.
Applegate GL; Marymont MH
Cancer Invest; 1998; 16(8):588-93. PubMed ID: 9844619
[TBL] [Abstract][Full Text] [Related]
54. Postoperative radiotherapy of intracranial ependymoma in pediatric and adult patients.
Shaw EG; Evans RG; Scheithauer BW; Ilstrup DM; Earle JD
Int J Radiat Oncol Biol Phys; 1987 Oct; 13(10):1457-62. PubMed ID: 3624024
[TBL] [Abstract][Full Text] [Related]
55. Spinal ependymoma in adults: a multicenter investigation of surgical outcome and progression-free survival.
Wostrack M; Ringel F; Eicker SO; Jägersberg M; Schaller K; Kerschbaumer J; Thomé C; Shiban E; Stoffel M; Friedrich B; Kehl V; Vajkoczy P; Meyer B; Onken J
J Neurosurg Spine; 2018 Jun; 28(6):654-662. PubMed ID: 29521579
[TBL] [Abstract][Full Text] [Related]
56. Chromosomal anomalies and prognostic markers for intracranial and spinal ependymomas.
Yang I; Nagasawa DT; Kim W; Spasic M; Trang A; Lu DC; Martin NA
J Clin Neurosci; 2012 Jun; 19(6):779-85. PubMed ID: 22516549
[TBL] [Abstract][Full Text] [Related]
57. Ependymomas in adults.
Gilbert MR; Ruda R; Soffietti R
Curr Neurol Neurosci Rep; 2010 May; 10(3):240-7. PubMed ID: 20425040
[TBL] [Abstract][Full Text] [Related]
58. Telomerase activation in posterior fossa group A ependymomas is associated with dismal prognosis and chromosome 1q gain.
Gojo J; Lötsch D; Spiegl-Kreinecker S; Pajtler KW; Neumayer K; Korbel P; Araki A; Brandstetter A; Mohr T; Hovestadt V; Chavez L; Kirchhofer D; Ricken G; Stefanits H; Korshunov A; Pfister SM; Dieckmann K; Azizi AA; Czech T; Filipits M; Kool M; Peyrl A; Slavc I; Berger W; Haberler C
Neuro Oncol; 2017 Sep; 19(9):1183-1194. PubMed ID: 28371821
[TBL] [Abstract][Full Text] [Related]
59. Clear cell ependymoma of the temporal lobe in a child: a case report.
Seyithanoglu H; Guzey FK; Emel E; Alatas I; Acarbas A; Ozkan N
Pediatr Neurosurg; 2008; 44(1):79-84. PubMed ID: 18097199
[TBL] [Abstract][Full Text] [Related]
60. Prognostic factors and treatment options for paediatric ependymomas.
Vaidya K; Smee R; Williams JR
J Clin Neurosci; 2012 Sep; 19(9):1228-35. PubMed ID: 22840355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]